DNA X, Inc. (SONM)
NASDAQ: SONM · Real-Time Price · USD
3.130
-0.110 (-3.40%)
At close: Sep 8, 2026, 4:00 PM EDT
3.170
+0.040 (1.28%)
After-hours: Sep 8, 2026, 7:30 PM EDT
DNA X Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| - | - | - | 93.63 | 69.83 | 54.57 | |
Revenue Growth | - | - | - | 34.09% | 27.96% | -14.72% |
Cost of Revenue | - | - | - | 74.31 | 58.21 | 48.16 |
Gross Profit | - | - | - | 19.32 | 11.62 | 6.41 |
Selling, General & Admin | 6.06 | 5.41 | 3.1 | 17.04 | 16.74 | 26.72 |
Research & Development | - | - | - | 1.77 | 7.97 | 17.7 |
Operating Expenses | 6.06 | 5.41 | 3.1 | 18.81 | 24.71 | 44.42 |
Operating Income | -6.06 | -5.41 | -3.1 | 0.51 | -13.09 | -38 |
Interest Expense | -1.28 | -1.49 | -0.03 | -0.02 | -0.1 | - |
Currency Exchange Gain (Loss) | - | - | 0.25 | -0.24 | -0.1 | -0.38 |
Other Non Operating Income (Expenses) | -0.55 | -0.31 | - | 0.02 | -0.01 | -0.08 |
EBT Excluding Unusual Items | -7.84 | -7.2 | -2.88 | 0.28 | -13.3 | -38.46 |
Merger & Restructuring Charges | -1.9 | - | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.13 | - |
Other Unusual Items | -0.57 | -0.76 | - | - | -0.47 | - |
Pretax Income | -10.3 | -7.96 | -2.88 | 0.28 | -13.9 | -38.46 |
Income Tax Expense | - | - | - | 0.37 | 0.18 | 0.17 |
Earnings From Continuing Operations | -10.3 | -7.96 | -2.88 | -0.09 | -14.09 | -38.63 |
Earnings From Discontinued Operations | 1.75 | -12.7 | -30.77 | - | - | - |
Net Income | -8.55 | -20.66 | -33.65 | -0.09 | -14.09 | -38.63 |
Net Income to Common | -8.55 | -20.66 | -33.65 | -0.09 | -14.09 | -38.63 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 |
Shares Change | 233.44% | 175.71% | 10.04% | 48.42% | 205.23% | 104.83% |
EPS (Basic) | -7.35 | -28.58 | -128.37 | -0.38 | -87.77 | -734.62 |
EPS (Diluted) | -7.35 | -28.58 | -128.37 | -0.38 | -87.77 | -734.62 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -14.51 | -23.53 | -8.7 | -4.09 | -12.37 | -38.52 |
Free Cash Flow Per Share | -12.47 | -32.55 | -33.19 | -17.16 | -77.06 | -732.62 |
Gross Margin | - | - | - | 20.64% | 16.64% | 11.75% |
Operating Margin | - | - | - | 0.55% | -18.75% | -69.64% |
Profit Margin | - | - | - | -0.10% | -20.17% | -70.78% |
Free Cash Flow Margin | - | - | - | -4.37% | -17.71% | -70.59% |
EBITDA | -3.48 | -1.11 | 0.46 | 0.56 | -11.11 | -35.87 |
EBITDA Margin | - | - | - | 0.60% | -15.92% | -65.74% |
D&A For EBITDA | 2.58 | 4.3 | 3.56 | 0.05 | 1.98 | 2.13 |
EBIT | -6.06 | -5.41 | -3.1 | 0.51 | -13.09 | -38 |
EBIT Margin | - | - | - | 0.55% | -18.75% | -69.64% |
Effective Tax Rate | - | - | - | 131.69% | - | - |
Revenue as Reported | - | - | - | 93.63 | - | - |